29
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2494 |
Cilengitide
西仑吉肽,EMD 121974 |
Integrin; Autophagy | Autophagy; Cytoskeletal Signaling |
Cilengitide (EMD 121974) 是一种有效的 αvβ3/5 受体整合素抑制剂,可抑制 ανβ3和 ανβ5与玻连蛋白结合,IC50值分别为 4 和 79 nM。 | |||
T21785 |
AG957
|
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Tyrphostin AG957 是一种酪氨酸激酶抑制剂,具有抗BCR/ABL 酪氨酸激酶活性。它能够抑制p210bcr/abl 酶活性 (IC50:2.9 μM)。 | |||
T5310 |
TR-14035
MDK-1191 |
Integrin | Cytoskeletal Signaling |
TR-14035 (MDK-1191) 是一种具有口服活性的 α4β7/α4β1整合素双重抑制剂,对 α4β7和 α4β1作用的 IC50值分别为 7 和 87 nM,可用于炎症和自体免疫疾病的研究。 | |||
T7566L1 |
GRGDSPK acetate
GRGDSPK acetate(111119-28-9 Free base) |
Beta Amyloid | Neuroscience |
GRGDSPK acetate 显示出对整合素-纤连蛋白结合的抑制活性,可用于研究整合素在骨形成和吸收中的作用。 | |||
TQ0250 |
CWHM-12
|
Integrin | Cytoskeletal Signaling |
CWHM-12 是 αV 整合素的有效抑制剂,抑制αvβ8、αvβ3、αvβ6和αvβ1,IC50 为 0.2、0.8、1.5 和 1.8 nM。 | |||
T6966 |
RGD
RGD (Arg-Gly-Asp) Peptides,Arg-Gly-Asp,RGD Peptides |
Integrin | Cytoskeletal Signaling |
RGD (RGD (Arg-Gly-Asp) Peptides) 是一种细胞粘附基序,可以模拟细胞粘附蛋白并与整合素结合。 | |||
T2537 |
Tirofiban hydrochloride monohydrate
Tirofiban Hydrochloride,盐酸替罗非班水合物,MK-383 Hydrochloride,盐酸替罗非班 |
ATPase; Integrin | Cytoskeletal Signaling; Membrane transporter/Ion channel |
Tirofiban hydrochloride monohydrate (MK-383 Hydrochloride) 是一种非肽类糖蛋白IIb/IIIa 的拮抗剂。 | |||
T4613 |
Arg-Gly-Asp TFA (99896-85-2(free base))
RGD Trifluoroacetate,RGD |
Integrin | Cytoskeletal Signaling |
Arg-Gly-Asp TFA (99896-85-2(free base)) (RGD Trifluoroacetate) 是一种三肽,可有效触发细胞粘附、定位某些细胞系并引发特定的细胞反应;与整合素结合。 | |||
T39933 |
Bexotegrast
PLN-74809 |
Integrin | Cytoskeletal Signaling |
Bexotegrast (PLN-74809)是一种具有口服活性和强效性的 αvβ6和αvβ1 整合素抑制剂,具有抗纤维化作用,抑制 αvβ6 和 αvβ1 诱导的 TGF-β 激活,可用于研究特发性肺纤维化(IPF)和非特异性间质性肺炎(NSIP)。 | |||
T26887 |
BOP
|
||
BOP is anantagonist of alpha4beta1/alpha9beta1 integrins. BOP rapidly mobilizes long-term multi-lineage reconstituting hematopoietic stem cells (HSC). | |||
T69517 | Bexotegrast HCl | ||
Bexotegrast, also known as PLN-74809, is a small-molecule, dual selective inhibitor of αVβ1 / αVβ6 for idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC). These integrins cause upstream activation of TGF-β1 in actively fibrotic tissue. Inhibition of these integrins will block TGF-β1 activation, thereby preventing the growth of fibrotic tissue within the lung and bile ducts. | |||
T16875 |
SF1126
|
Others | Others |
SF1126 is a relevant pan and dual first-in-class PI3K/BRD4 inhibitor. SF1126 is an RGDS-conjugated LY294002 prodrug, which is designed to exhibit increased solubility and bind to specific integrins within the tumor compartment. | |||
T38793 |
THI0019
THI0019 |
||
THI0019 is a highly potent agonist of the integrin α4β1 (VLA-4) receptor, with an EC 50 range of 1-2 μM. It effectively promotes the adhesion of stem/progenitor cells. Furthermore, THI0019 successfully modulates adhesion processes mediated by α4β7, α5β1, and αLβ2 integrins. | |||
T16851 | SB-267268 | Others | Others |
SB-267268 inhibits human and mouse αvβ3 (IC50s: 0.68 and 0.29 nM, respectively). SB-267268 is a selective and nonpeptidic alpha(v)beta3 and alpha(v)beta5 integrins antagonist (Kis: 0.9, 0.5 and 0.7 nM for human αvβ3, monkey αvβ3 and human αvβ5, respective | |||
T81283 |
RGD-targeted Proapoptotic Peptide
|
||
RGD-targeted Proapoptotic Peptide为一肽类化合物,其C端RGD-4C肽段(ACDCRGDCFC)能够特异性地与肿瘤新生血管的整合素结合位点优先结合。 | |||
T70083 |
Cilengitide hydrochloride
|
||
Cilengitide hydrochloride sis the salt form of Cilengitide, a cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. | |||
T80214 |
cRGDfK-thioacetyl ester
|
Integrin | Cytoskeletal Signaling |
cRGDfK-thioacetyl ester 为具选择性亲和力于整合素(integrins)之生物活性多肽。可应用于修饰NIR荧光探针,实现癌症靶向成像。 | |||
TP1555 |
Fibronectin Active Fragment Control
|
||
Fibronectin is a high-molecular weight (~440kDa) extracellular matrix glycoprotein that binds to membrane-spanning receptor proteins called integrins.In addition to integrins, fibronectin also binds extracellular matrix components such as collagen, fibrin | |||
T82359 |
G-{d-Arg}-GDSP
|
||
G-{d-Arg}-GDSP为RGD多肽类似物,具有与整合素粘附受体结合的能力,能够抑制细胞对纤维连接蛋白的附着及破骨细胞的重吸收。 | |||
T41153 |
BOP-JF646
BOP-JF646 |
||
BOP-JF646 is a fluorescent dual α9β1/α4β1 integrin inhibitor. Comprises BOP conjugated to Janelia Fluor®646. Fluorogenic: fluoresces only once bound to integrins, enabling hassle-free no-wash experiments. Bright and photostable, enabling live cell tracking of integrin receptors over long time-course experiments. Excitation maximum = 655 nm; emission maximum = 672 nm. | |||
T79792 |
αvβ1 integrin-IN-2
|
Integrin | Cytoskeletal Signaling |
αvβ1integrin-IN-2(compound 32)作为整合素ανβ1与α5β1的抑制剂,展现出高效性,其IC50值分别为0.9 nM和33 nM。此外,该化合物对其他整合素亦有抑制作用,其IC50分别为380 nM(ανβ3)、280 nM(ανβ5)、230 nM(ανβ6)、87 nM(ανβ8)。 | |||
T41149 |
BOP-JF549
BOP-JF549 |
||
BOP-JF549 is a fluorescent dual α9β1/α4β1 integrin inhibitor. Comprises BOP conjugated to Janelia Fluor® 549. Fluorogenic: fluoresces only once bound to integrins, enabling hassle-free no-wash experiments. Bright and photostable, enabling live cell tracking of integrin receptors over long time-course experiments. Excitation maximum = 549 nm; emission maximum = 571 nm. | |||
T77154 | Etrolizumab | ||
Etrolizumab (rhuMAb Beta7) 是一种肠道选择性抗-β7整合素单克隆抗体。Etrolizuma b 是针对α4β7和 αEβ7 整合素的 β7 亚基的特异性靶向活性分子。Etrolizumab 可用于炎症性肠病 (IBD) 的研究。 | |||
T76255 |
Certepetide
|
||
Certepetide (CEND-1),即双功能环肽(a.k.a. iRGD),是一种具有穿透肿瘤功能的多肽。通过与α-V整联蛋白(alphav-integrins)的RGD motif相互作用,以及激活神经纤毛蛋白1(NRP-1),Certepetide能够将实体瘤微环境转化成临时的活性分子通道,从而在肿瘤中累积。该化合物在胰腺癌和其他实体瘤的研究中具有应用潜力。 | |||
T75765 |
GRGDSPK TFA
|
||
GRGDSPK TFA (EMD 56574 TFA) 是一种含有精氨酸-甘氨酸-天冬氨酸 (RGD) 序列的多肽。作为竞争性且可逆的抑制剂,它能够抑制整联蛋白与纤连蛋白的结合,用于探究整联蛋白在骨形成及吸收过程中的功能。 | |||
TP1343 |
RGD Trifluoroacetate
|
||
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; RGD Trifluoroacetate binds to integrins.RGD Trifluoroacetate is the most effective and most often employed pept | |||
T36296 | BIO5192 hydrate | ||
BIO5192 hydrate is a selective and potent integrin α4β1 (VLA-4) inhibitor (Kd<10 pM). BIO5192 hydrate selectively binds to α4β1 (IC50=1.8 nM) over a range of other integrins. BIO5192 hydrate results in a 30-fold increase in mobilization of murine hematopoietic stem and progenitors (HSPCs) over basal levels[1][2]. The combination of BIO5192 hydrate (1 mg/kg; i.v.) and Plerixafor (5 mg/kg; s.c.) exert an additive effect on progenitor mobilization[1].BIO5192 hydrate (30 mg/kg; s.c; bid; during days... | |||
T82379 |
FN-A208 fusion peptide
|
||
FN-A208 是源自鼠层粘连蛋白 a1 的 A208 与纤连蛋白 (GRGDS) 活性位点和甘氨酸间隔区融合形成的生物活性肽。该肽能形成淀粉样原纤维,并有助于促进肌动蛋白应力纤维的形成,进而介导成纤维细胞附着,显示出其在组织再生和工程生物粘合剂方面的应用潜力。FN-A208 与 IKVAV 受体和整合素发生相互作用,而在 EDTA 存在下,其活性则会被破坏。 | |||
T36291 | Integrin modulator 1 | ||
Integrin modulator 1 is a potent and selective α4β1 integrin agonist, with an IC50 of 9.8 nM for RGD-binding α4β1. Integrin modulator 1 increases cell adhesion mediated by α4β1 integrin, with an EC50 of 12.9 nM[1]. Integrin modulator 1 (2-10 μg/mL; 30 min) significantly increases Jurkat E6.1 cell adhesion[1].Integrin modulator 1 (1-100 nM; 1 h) strongly and significantly increases ERK1/2 phosphorylation in Jurkat E6.1 cells[1].Integrin modulator 1 (1 nM-10 μM; 30 min) significantly increases the... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36295 | Echistatin TFA | ||
Echistatin TFA, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation. Echistatin is a potent inhibitor of bone resorption in culture. Echistatin is a potent antagonist of αIIbβ3, αvβ3 and α5β1[1][2][3][4]. [1]. J Musial, et al. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Circulation. 1990 Jul;82(1):261-73.[2]. ... |